Rare diseases in children-Knowledge, experiences and challenges faced by pediatricians in Tanzania

Mariam Noorani1,2, Mohamedraza Ebrahim1, Francis Furia2

  • 1Department of Pediatrics, Aga Khan University, Dar es Salaam, Tanzania.

Insights

Pediatricians in Tanzania frequently encounter rare childhood diseases but face significant challenges in diagnosis and treatment due to limited access to testing and expert support. Improving rare disease care requires better training and accessible diagnostics.

Area of Science:

  • Pediatric rare disease diagnosis and management
  • Global health challenges in pediatric care
  • Tanzanian healthcare system analysis

Background:

  • Diagnosing and treating rare diseases in children presents global challenges for pediatricians.
  • Limited knowledge and inaccessible diagnostic testing often lead to delayed care for rare pediatric conditions.
  • The specific experiences and challenges faced by pediatricians in Tanzania regarding rare diseases were previously unknown.

Purpose of the Study:

  • To assess Tanzanian pediatricians' knowledge of rare diseases.
  • To understand their experiences and challenges in treating children with rare diseases.
  • To identify barriers to effective rare disease care in Tanzania.

Main Methods:

  • A nationwide cross-sectional online survey was conducted.
  • The survey targeted pediatricians registered with the Pediatric Association of Tanzania.
  • 168 pediatricians completed the survey, yielding a 52% response rate.

Main Results:

  • All surveyed pediatricians had encountered presumed rare diseases, with 60% seeing cases recently.
  • The most common challenge was lack of access to diagnostic testing (97%).
  • Significant gaps exist in training (only 33% taught in university), confidence (60% felt unprepared), and access to expert advice (75% unable to consult experts).

Conclusions:

  • Pediatricians in Tanzania commonly encounter rare diseases but face substantial obstacles in diagnostics, training, and expert consultation.
  • Improving care necessitates making diagnostic testing available, affordable, and accessible.
  • Medical curricula need revision to include rare disease education, and expert consultation pathways must be established.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Ethical Dilemmas I01:17

Ethical Dilemmas I

Ethical dilemmas in nursing are of utmost importance, as they often arise from the tension between adhering to core ethical principles and the practical realities of healthcare delivery. These dilemmas require nurses to navigate complex situations where competing ethical considerations pull them in different directions.
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...